Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

FDA recall notice · announced March 27, 2024 · Novitium Pharma

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Reason for recall

Cross Contamination with Other Products:(mycophenolate mofetil).

Notes

Distribution: Nationwide in the USA
Lot/code information: Lot #: M23172A, Exp 01/31/2025
Quantity: 3,940 1000-count bottles
Status: Terminated
Products in this recall event:
- Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20 (D-0389-2024)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.